Aims: This study assessedtheoutcomes as a result of hospital transfer and delays in trauma patients.
2
In this study, we assessedtheoutcomes of patients who, after BMT, had BE and those who did not.
3
We assessedtheoutcomes of patients older than 54 years who received unrelated donor transplants for the treatment of myeloid malignancies in our institution.
4
We assessedtheoutcomes of all consecutive newly diagnosed pediatric patients with LCH with SS-MFB lesions who were treated with JLSG-02 protocol in 2002-2009.